Literature DB >> 29788546

In vitro penetration through the skin layers of topically applied glucocorticoids.

Victor Carrer1, Cristina Alonso1, Marc Adrià Oliver1, Luisa Coderch1.   

Abstract

Corticoids are actives widely used in the treatment of skin diseases. This work aims to study the penetration of 3 corticoids (betamethasone, clobetasol, and flurandrenolide), their relationship with their Log D values and the effects of the vehicles. The 3 compounds were applied on a Franz-type diffusion cell in propylene glycol solution and their respective commercial creams and ointments. The active amounts found in the stratum corneum, epidermal, and dermal layers of the skin were investigated. Their diffusions were greatly affected by the formulation; moreover higher amounts of substance in the epidermis and dermis were detected in ointments than in creams. The enhancement effect of propylene glycol was also observed. The differences between the 3 substances could be related to their lipophilicity, molecular structure, and molecular weight. The more hydrophobic compounds (clobetasol and betamethasone) are present in higher amounts in the epidermis and dermis, while the hydrophilic compound (flurandrenolide) is mostly present in the receptor fluid.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  clobetasol; corticosteroids; flurandrenolide; percutaneous absorption; propylene glycol

Mesh:

Substances:

Year:  2018        PMID: 29788546     DOI: 10.1002/dta.2412

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  2 in total

Review 1.  Biochemical, structural and physical changes in aging human skin, and their relationship.

Authors:  Seungman Park
Journal:  Biogerontology       Date:  2022-03-15       Impact factor: 4.284

2.  Assessment of Finite and Infinite Dose In Vitro Experiments in Transdermal Drug Delivery.

Authors:  Luisa Coderch; Ilaria Collini; Victor Carrer; Clara Barba; Cristina Alonso
Journal:  Pharmaceutics       Date:  2021-03-10       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.